HomeHRTX • NASDAQ
add
Heron Therapeutics Inc
Previous close
$2.47
Day range
$2.21 - $2.48
Year range
$1.04 - $3.93
Market cap
340.69M USD
Avg Volume
1.85M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 40.78M | 19.13% |
Operating expense | 23.20M | 76.23% |
Net income | 3.66M | 134.16% |
Net profit margin | 8.98 | 128.66% |
Earnings per share | 0.02 | 128.57% |
EBITDA | 4.75M | -41.27% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 59.28M | -26.27% |
Total assets | 233.15M | 4.78% |
Total liabilities | 266.80M | 4.02% |
Total equity | -33.65M | — |
Shares outstanding | 152.33M | — |
Price to book | -11.23 | — |
Return on assets | 4.60% | — |
Return on capital | 7.39% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 3.66M | 134.16% |
Cash from operations | -11.78M | -579.84% |
Cash from investing | 11.42M | 229.22% |
Cash from financing | 423.00K | 112.56% |
Net change in cash | 61.00K | 100.99% |
Free cash flow | -16.25M | -199.43% |
About
Founded
1983
Headquarters
Website
Employees
122
